75380-94-8 Usage
Uses
Used in Pharmaceutical Industry:
2-METHYL-4-OXO-4-(3'-FLUOROPHENYL)BUTYRIC ACID is used as a key intermediate in the synthesis of various pharmaceuticals and drugs. Its unique structure allows it to be a valuable component in the development of new medications.
Used in Organic Chemistry Research:
In the field of organic chemistry, 2-METHYL-4-OXO-4-(3'-FLUOROPHENYL)BUTYRIC ACID is utilized as an intermediate for the synthesis of complex organic compounds, contributing to the advancement of chemical knowledge and the creation of novel chemical entities.
Used in Medical Research and Drug Discovery:
Due to its distinctive chemical properties, 2-METHYL-4-OXO-4-(3'-FLUOROPHENYL)BUTYRIC ACID may be employed in medical research and drug discovery, potentially leading to the development of innovative treatments and therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 75380-94-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,3,8 and 0 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 75380-94:
(7*7)+(6*5)+(5*3)+(4*8)+(3*0)+(2*9)+(1*4)=148
148 % 10 = 8
So 75380-94-8 is a valid CAS Registry Number.
75380-94-8Relevant academic research and scientific papers
4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
-
, (2008/06/13)
4-phenyl-4-oxo-butanoic acid derivatives for use in the treatment of the human or animal body by therepy; particularly as kynurenine-3-hydroxylase inhibitors, in the prevention and/or treatment of a neurodegenerative disease wherein the inhibition of such an enyzme is needed. The present invention further comprises a selected class of the above mentioned 4-phenyl-4-oxo-butanoic acid derivatives, their pharmaceutically acceptable salts, a process for their preparation and pharmaceutical compositions containing them.
Spiro-3-hetero-azolones for treatment of diabetic complications
-
, (2008/06/13)
Spiro-oxazolidones, -thiazolidones and -imidazolidones are disclosed which are useful as aldose reductase inhibitors and as therapeutic agents for the treatment of complications arising from diabetes. Pharmaceutical compositions containing the spiro compo
SUBSTITUTED THIO-SUBSTITUTED BENZYL-PROPIONYL-L-PROLINES
-
, (2008/06/13)
This disclosure describes novel substituted ω-aroyl(propionyl or butyryl)-L-prolines and the esters and cationic salts thereof which are useful as hypotensive agents in mammals.
